Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1432-1459
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy ; day:2 ; month:5 ; year:2020 ; pages:1-10
Journal of neurology ; (2.5.2020), 1-10

Creator
Osmanovic, Alma
Ranxha, Gresa
Kumpe, Mareike
Müschen, Lars
Binz, Camilla
Wiehler, Flavia
Paracka, Lejla
Körner, Sonja
Kollewe, Katja
Petri, Susanne
Schreiber-Katz, Olivia
Contributor
SpringerLink (Online service)

DOI
10.1007/s00415-020-09847-8
URN
urn:nbn:de:101:1-2020071123521758856191
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:56 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Osmanovic, Alma
  • Ranxha, Gresa
  • Kumpe, Mareike
  • Müschen, Lars
  • Binz, Camilla
  • Wiehler, Flavia
  • Paracka, Lejla
  • Körner, Sonja
  • Kollewe, Katja
  • Petri, Susanne
  • Schreiber-Katz, Olivia
  • SpringerLink (Online service)

Other Objects (12)

Nusinersen: A Review in 5q Spinal Muscular Atrophy

Nusinersen: A Review in 5q Spinal Muscular Atrophy

Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients

Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients

Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen

Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen

Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy

Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy

Correction to: Nusinersen: A Review in 5q Spinal Muscular Atrophy

Correction to: Nusinersen: A Review in 5q Spinal Muscular Atrophy

Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy

Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy

Evaluation of Metabolic Effects of Nusinersen in Patients with Spinal Muscular Atrophy

Evaluation of Metabolic Effects of Nusinersen in Patients with Spinal Muscular Atrophy

Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen

Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen

Profiling neuroinflammatory markers and response to nusinersen in paediatric spinal muscular atrophy

Profiling neuroinflammatory markers and response to nusinersen in paediatric spinal muscular atrophy

Proteomics profiling and machine learning in nusinersen-treated patients with spinal muscular atrophy

Proteomics profiling and machine learning in nusinersen-treated patients with spinal muscular atrophy

Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis

Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis

Cathepsin D as biomarker in CSF of nusinersen‐treated patients with spinal muscular atrophy

Cathepsin D as biomarker in CSF of nusinersen‐treated patients with spinal muscular atrophy

Related objects